Search - tctmd.com

Displaying 81 - 100 of 103

Sort: Relevancy | Date

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

News Daily News

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

May 24, 2013

News Daily News

一项注册研究旨在探索面向低至中等风险患者的经皮主动脉瓣置换（TAVR）可行方案

May 13, 2013

News Daily News

Un Estudio de Registro Explora las Posibilidades de la TAVR en Pacientes de Riesgo Bajo, Intermedio

May 13, 2013

News Daily News

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

May 13, 2013

News Daily News

Registros Europeos revelan Beneficios Claros en los Resultados de la TAVR

Caitlin E. Cox

January 13, 2013

News Daily News

European Registries Show Solid Gains in TAVR Outcomes

Caitlin E. Cox

January 13, 2013

News Industry News

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

November 15, 2012

Presentation TCT 2012

Update from the Randomized SURTAVI Trial

Presenter: Patrick Serruys

October 22, 2012

News Industry News

Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial

September 05, 2012

News Daily News

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

August 02, 2012

News Daily News

Según un Análisis del BMJ el uso de la TAVR en Europa Sobrepasa a las Evidencias

August 02, 2012

News Industry News

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

July 18, 2012

Presentation TVT 2012

SURTAVI Update

Presenter: Patrick Serruys

June 05, 2012

News Daily News

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

March 06, 2012

News Daily News

La Selección de Pacientes Seleccionados para recibir un Tratamiento de Válvula Transcateter son cada vez Más Jóvenes y de Menor Riesgo

March 06, 2012

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Daily News

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

L.A. McKeown

January 13, 2011

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Video

» Interview

SURTAVI: TAVI vs SAVR Through 5 Years

November 6, 2021

Advertisement

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

一项注册研究旨在探索面向低至中等风险患者的经皮主动脉瓣置换（TAVR）可行方案

Un Estudio de Registro Explora las Posibilidades de la TAVR en Pacientes de Riesgo Bajo, Intermedio

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

Registros Europeos revelan Beneficios Claros en los Resultados de la TAVR

European Registries Show Solid Gains in TAVR Outcomes

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

Update from the Randomized SURTAVI Trial

Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

Según un Análisis del BMJ el uso de la TAVR en Europa Sobrepasa a las Evidencias

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

SURTAVI Update

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

La Selección de Pacientes Seleccionados para recibir un Tratamiento de Válvula Transcateter son cada vez Más Jóvenes y de Menor Riesgo

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

SURTAVI: TAVI vs SAVR Through 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content